This compound is a pharmaceutical intermediate used in the synthesis of other chemical substances. It features ester and ether functional groups, contributing to its polarity and suitability as a building block in organic synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1335210-26-8
7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-(1,3)oxazino(3,2-d)pyrido(1,2-a)pyrazine-9-carboxylic acid, (4R,12AS)-
pharmaceutical intermediate
(4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
pharmaceutical intermediate
Piperazine-2-carboxylic acid dihydrochloride
Pharmaceutical intermediate
(2S,5S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
Pharmaceutical intermediate for antiviral synthesis
methyl (Z)-2-(2,2-dimethoxyethyliminomethyl)-3-hydroxy-4-methoxybut-2-enoate
GRLJKSJRPHQCBX-HFCDSVAESA-N
COC/C(=C(\C=NCC(OC)OC)/C(=O)OC)/O
—